E. Ohman J or Asset Management AB Raises Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

E. Ohman J or Asset Management AB increased its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 10.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 20,300 shares of the company’s stock after buying an additional 2,000 shares during the period. E. Ohman J or Asset Management AB’s holdings in GE HealthCare Technologies were worth $1,587,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in GEHC. Mather Group LLC. increased its position in GE HealthCare Technologies by 14.3% during the 4th quarter. Mather Group LLC. now owns 1,977 shares of the company’s stock valued at $155,000 after purchasing an additional 247 shares during the period. Brown Lisle Cummings Inc. increased its holdings in GE HealthCare Technologies by 33.0% during the fourth quarter. Brown Lisle Cummings Inc. now owns 605 shares of the company’s stock valued at $47,000 after buying an additional 150 shares during the period. Tandem Capital Management Corp ADV raised its stake in GE HealthCare Technologies by 0.4% in the fourth quarter. Tandem Capital Management Corp ADV now owns 28,210 shares of the company’s stock worth $2,205,000 after buying an additional 118 shares in the last quarter. Optas LLC lifted its holdings in GE HealthCare Technologies by 11.3% during the fourth quarter. Optas LLC now owns 2,937 shares of the company’s stock worth $230,000 after buying an additional 298 shares during the period. Finally, Jennison Associates LLC increased its holdings in shares of GE HealthCare Technologies by 124.5% in the 4th quarter. Jennison Associates LLC now owns 1,709,635 shares of the company’s stock valued at $133,659,000 after acquiring an additional 948,017 shares during the period. 82.06% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the company. Wells Fargo & Company raised their price objective on GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a research report on Thursday, October 31st. Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $96.00.

GE HealthCare Technologies Trading Down 0.7 %

NASDAQ GEHC opened at $86.93 on Wednesday. The stock has a market cap of $39.72 billion, a P/E ratio of 23.88, a P/E/G ratio of 2.92 and a beta of 1.14. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12. GE HealthCare Technologies Inc. has a 12-month low of $72.61 and a 12-month high of $94.55. The company has a fifty day simple moving average of $83.06 and a two-hundred day simple moving average of $85.13.

GE HealthCare Technologies Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be given a dividend of $0.035 per share. The ex-dividend date is Tuesday, January 14th. This represents a $0.14 dividend on an annualized basis and a yield of 0.16%. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s payout ratio is currently 3.85%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.